BORON NEUTRON CAPTURE THERAPY

Boron neutron capture therapy (BNCT) for locally recurrent and locally advanced head and neck cancer using the boron agent, borofalan (10B) and the accelerator-based BNCT treatment system began with the public insurance coverage in June 2020. This therapy is based on the transmutation reaction of bo...

Full description

Saved in:
Bibliographic Details
Published inJIBI INKOKA TEMBO Vol. 64; no. 6; pp. 360 - 367
Main Authors Hirose, Katsumi, Sato, Mariko, Harada, Mayumi, Takai, Yoshihiro
Format Journal Article
LanguageJapanese
Published Society of Oto-rhino-laryngology Tokyo 15.12.2021
Subjects
borofalan (10B)
Boron Neutron Capture Therapy (BNCT)
recurrent head and neck cancer
Online AccessGet full text

Cover

More Information
Summary:Boron neutron capture therapy (BNCT) for locally recurrent and locally advanced head and neck cancer using the boron agent, borofalan (10B) and the accelerator-based BNCT treatment system began with the public insurance coverage in June 2020. This therapy is based on the transmutation reaction of boron-10 and neutrons, and enables tumor-selective treatment based on the accumulation of boron agents. However, since the neutrons used in BNCT do not reach deep into the body, it may be difficult to provide effective treatment to patients with deep-seated tumors. Therefore, it is desirable to use this treatment method as early as possible as a treatment option for patients who are found to have local recurrence.
ISSN:0386-9687
1883-6429
DOI:10.11453/orltokyo.64.6_360